CIBC World Market
REGN icon

CIBC World Market’s Regeneron Pharmaceuticals REGN Stock Holding History

CIBC World Market’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Sell
3,766
-6,096
-62% -$4.67M ﹤0.01% 680
2025
Q4 		$7.61M Sell
9,862
-5,871
-37% -$3.99M 0.01% 483
2025
Q3 		$8.85M Buy
15,733
+10,999
+232% +$6.22M 0.02% 439
2025
Q2 		$2.49M Buy
4,734
+2,164
+84% +$1.21M ﹤0.01% 681
2025
Q1 		$1.63M Buy
2,570
+1,439
+127% +$990K ﹤0.01% 770
2024
Q4 		$806K Sell
1,131
-193
-15% -$162K ﹤0.01% 927
2024
Q3 		$1.39M Sell
1,324
-44
-3% -$49K ﹤0.01% 764
2024
Q2 		$1.44M Buy
1,368
+211
+18% +$205K ﹤0.01% 721
2024
Q1 		$1.11M Sell
1,157
-8
-0.7% -$7.61K ﹤0.01% 786
2023
Q4 		$1.02M Buy
1,165
+20
+2% +$16.5K ﹤0.01% 753
2023
Q3 		$942K Buy
1,145
+181
+19% +$142K ﹤0.01% 749
2023
Q2 		$693K Sell
964
-1,163
-55% -$897K ﹤0.01% 854
2023
Q1 		$1.75M Sell
2,127
-309
-13% -$233K 0.01% 620
2022
Q4 		$1.76M Buy
2,436
+277
+13% +$204K 0.01% 618
2022
Q3 		$1.49M Sell
2,159
-2,922
-58% -$1.84M 0.01% 627
2022
Q2 		$3M Sell
5,081
-1,335
-21% -$868K 0.01% 454
2022
Q1 		$4.48M Buy
6,416
+86
+1% +$54.4K 0.01% 402
2021
Q4 		$4M Sell
6,330
-1,703
-21% -$1.05M 0.01% 440
2021
Q3 		$4.86M Buy
8,033
+3,563
+80% +$2.21M 0.02% 373
2021
Q2 		$2.5M Buy
4,470
+1,082
+32% +$548K 0.01% 531
2021
Q1 		$1.6M Sell
3,388
-441
-12% -$215K ﹤0.01% 645
2020
Q4 		$1.85M Buy
3,829
+705
+23% +$381K 0.01% 587
2020
Q3 		$1.75M Sell
3,124
-9,430
-75% -$5.72M 0.01% 521
2020
Q2 		$7.83M Buy
12,554
+9,584
+323% +$5.44M 0.04% 217
2020
Q1 		$1.45M Sell
2,970
-6,893
-70% -$2.84M 0.01% 471
2019
Q4 		$3.7M Buy
9,863
+6,519
+195% +$2.19M 0.02% 366
2019
Q3 		$928K Buy
3,344
+1,118
+50% +$331K ﹤0.01% 656
2019
Q2 		$697K Buy
+2,226
New +$741K ﹤0.01% 739
2019
Q1 		– Sell
-648
Closed -$242K – 1216
2018
Q4 		$242K Sell
648
-8,320
-93% -$3.05M ﹤0.01% 958
2018
Q3 		$3.62M Buy
8,968
+5,802
+183% +$2.21M 0.02% 359
2018
Q2 		$1.09M Buy
3,166
+1,085
+52% +$339K ﹤0.01% 636
2018
Q1 		$717K Buy
2,081
+485
+30% +$169K ﹤0.01% 737
2017
Q4 		$600K Buy
1,596
+828
+108% +$335K ﹤0.01% 515
2017
Q3 		$343K Sell
768
-2,171
-74% -$1.03M ﹤0.01% 619
2017
Q2 		$1.44M Sell
2,939
-18,845
-87% -$8.25M 0.01% 547
2017
Q1 		$8.44M Buy
21,784
+20,833
+2,191% +$7.72M 0.03% 208
2016
Q4 		$349K Sell
951
-879
-48% -$334K ﹤0.01% 884
2016
Q3 		$736K Buy
1,830
+1,251
+216% +$502K ﹤0.01% 636
2016
Q2 		$202K Buy
+579
New +$223K ﹤0.01% 858
2016
Q1 		– Sell
-3,259
Closed -$1.77M – 920
2015
Q4 		$1.77M Buy
+3,259
New +$1.77M 0.01% 356
2015
Q3 		– Sell
-12,847
Closed -$6.55M – 940
2015
Q2 		$6.55M Buy
12,847
+10,495
+446% +$5.12M 0.03% 136
2015
Q1 		$1.06M Sell
2,352
-289
-11% -$122K ﹤0.01% 424
2014
Q4 		$1.08M Buy
+2,641
New +$1.04M ﹤0.01% 428

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CIBC World Market's REGN Position: Q1 2026 in Review

CIBC World Market reduced its Regeneron Pharmaceuticals (REGN) stake by 62% in Q1 2026, selling an estimated $4.67M and leaving 3,766 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #680.

CIBC World Market first reported a position in REGN in Q4 2014 and has held it in 43 quarters since. The position peaked at $8.85M in Q3 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • CIBC World Market held 3,766 shares of Regeneron Pharmaceuticals worth $2.91M as of Q1 2026.
  • CIBC World Market sold 6,096 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $4.67M.
  • Regeneron Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #680 holding.
  • CIBC World Market first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 43 quarters since.
  • CIBC World Market's Regeneron Pharmaceuticals position peaked at $8.85M in Q3 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.